<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To identify factors that determine disease severity and clinical phenotype of the most common spinocerebellar <z:hpo ids='HP_0001251'>ataxias</z:hpo> (SCAs), we studied 526 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA1</z:e>, SCA2, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e>. or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA6</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: To measure the severity of <z:hpo ids='HP_0001251'>ataxia</z:hpo> we used the Scale for the Assessment and Rating of <z:hpo ids='HP_0001251'>Ataxia</z:hpo> (SARA) </plain></SENT>
<SENT sid="2" pm="."><plain>In addition, nonataxia symptoms were assessed with the Inventory of Non-<z:hpo ids='HP_0001251'>Ataxia</z:hpo> Symptoms (INAS) </plain></SENT>
<SENT sid="3" pm="."><plain>The INAS count denotes the number of nonataxia symptoms in each patient </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: An analysis of covariance with SARA score as dependent variable and repeat lengths of the expanded and <z:mpath ids='MPATH_458'>normal</z:mpath> allele, age at <z:hpo ids='HP_0003674'>onset</z:hpo>, and disease duration as independent variables led to multivariate models that explained 60.4% of the SARA score variance in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA1</z:e>, 45.4% in SCA2, 46.8% in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e>, and 33.7% in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA6</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>In <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA1</z:e>, SCA2, and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e>, SARA was mainly determined by repeat length of the expanded allele, age at <z:hpo ids='HP_0003674'>onset</z:hpo>, and disease duration </plain></SENT>
<SENT sid="6" pm="."><plain>The only factors determining the SARA score in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA6</z:e> were age at <z:hpo ids='HP_0003674'>onset</z:hpo> and disease duration </plain></SENT>
<SENT sid="7" pm="."><plain>The INAS count was 5.0 +/- 2.3 in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA1</z:e>, 4.6 +/- 2.2 in SCA2, 5.2 +/- 2.5 in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e>, and 2.0 +/- 1.7 in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA6</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>In <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA1</z:e>, SCA2, and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e>, SARA score and disease duration were the strongest predictors of the INAS count </plain></SENT>
<SENT sid="9" pm="."><plain>In <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA6</z:e>, only age at <z:hpo ids='HP_0003674'>onset</z:hpo> and disease duration had an effect on the INAS count </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: Our study suggests that spinocerebellar <z:hpo ids='HP_0001251'>ataxia</z:hpo> (SCA) 1, SCA2, and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e> share a number of common biologic properties, whereas <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA6</z:e> is distinct in that its phenotype is more determined by age than by disease-related factors </plain></SENT>
</text></document>